| Jun 11 |
QIAGEN launches new QIAcuity digital PCR assays for microbial applications, enhancing infectious disease research and surveillance
|
| Jun 10 |
QIAGEN (QGEN) Unveils dPCR Tool, Enhances GeneGlobe Platform
|
| Jun 7 |
Editas (EDIT) Down 2.3% Since Last Earnings Report: Can It Rebound?
|
| Jun 6 |
QIAGEN to discontinue NeuMoDx, updates 2024 forecast
|
| Jun 6 |
QIAGEN to discontinue NeuMoDx integrated PCR testing system, support customers during transition period
|
| Jun 5 |
QIAGEN launches digital PCR Assay Design Tool for QIAcuity, expands customization capabilities of its research platform GeneGlobe
|
| Jun 5 |
Why Is Rocket Pharmaceuticals (RCKT) Down 4.8% Since Last Earnings Report?
|
| Jun 5 |
QIAGEN's (QGEN) New Launch Expands US Syndromic Testing Menu
|
| Jun 3 |
QIAGEN (QGEN) Advances Precision Medicine With New QIAseq Kit
|
| Jun 3 |
QIAGEN expands QIAstat-Dx syndromic testing menu in the U.S. with launch of molecular test to improve gastrointestinal care
|
